Cogent Biosciences (COGT) Retained Earnings (2017 - 2026)

Cogent Biosciences' Retained Earnings history runs 10 years deep, the most recent figure standing at -$1.3 billion for Q1 2026.

• In Q1 2026, Retained Earnings fell 784124.39% year-over-year to -$1.3 billion; the TTM figure through Mar 2026 stood at -$1.3 billion (down 784124.39% YoY), while the FY2025 annual figure was -$1.2 billion, down 265965.77% from the prior year.
• Retained Earnings was -$1.3 billion for Q1 2026 at Cogent Biosciences, down from -$1.2 billion in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of $447000.0 in Q4 2024 to a low of -$1.3 billion in Q1 2026.
• Historically, Retained Earnings has averaged -$468.8 million across 5 years, with a median of -$371.6 million in 2022.
• The sharpest annual moves came in 2025 and 2026: Retained Earnings soared 520.51% in 2025, then tumbled 784124.39% in 2026.
• A 5-year view of Retained Earnings shows it stood at -$104000.0 in 2022, then tumbled by 580307.69% to -$603.6 million in 2023, then jumped by 100.07% to $447000.0 in 2024, then tumbled by 265965.77% to -$1.2 billion in 2025, then retreated by 8.19% to -$1.3 billion in 2026.
• The last three Retained Earnings figures came in at -$1.3 billion (Q1 2026), -$1.2 billion (Q4 2025), and -$1.1 billion (Q3 2025), per Business Quant data.